Kremenak C R, Kinser D D, Melcher T J, Wright G R, Harrison S D, Ziaja R R, Harman H A, Ordahl J N, Demro J G, Menard C C
Department of Orthodontics, University of Iowa, Iowa City.
Am J Orthod Dentofacial Orthop. 1992 Jan;101(1):21-7. doi: 10.1016/0889-5406(92)70077-n.
Debate about orthodontic treatment as a risk factor for temporomandibular disorders (TMD) led to this study. This report, the second in a series, concerns findings from a longitudinal study in which 30 new orthodontic patients have been enrolled annually since 1983. The method of Helkimo was used to collect TMD data before initiation of orthodontic treatment, and at annual intervals after debanding. Treatment was by fixed edgewise appliances. Data from a pretreatment and at least one posttreatment Helkimo examination were available for 109 patients. Follow-up data were available for 92 patients in the first year after debanding, with the corresponding sample sizes declining to 56, 33, 19, 11, and 7 for the second through the sixth posttreatment years, respectively. Primary analyses involved comparison of mean scores from the Helkimo 25-point dysfunction index scale. There were no significant differences between mean pretreatment and posttreatment Helkimo scores for any of the various groupings except for small, clinically unimportant improvements seen in the 12 to 24 month subgroup of 55 patients and in the 48 to 60 month subgroup of 11 patients. With average follow-up time of about 2 years for the 109 patients, 90% had Helkimo scores that stayed the same or improved, and 10% had scores that increased or worsened from 2 to 5 Helkimo points. We conclude that the orthodontic treatment experienced by our sample was not an important etiologic factor for TMD.
关于正畸治疗作为颞下颌关节紊乱病(TMD)风险因素的争论引发了这项研究。本报告是系列报告中的第二篇,涉及一项纵向研究的结果,自1983年以来每年招募30名新的正畸患者。采用赫尔基莫方法在正畸治疗开始前以及拆除矫治器后每年收集TMD数据。治疗采用固定直丝弓矫治器。109名患者有治疗前和至少一次治疗后赫尔基莫检查的数据。拆除矫治器后第一年有92名患者的随访数据,治疗后第二年至第六年相应的样本量分别降至56、33、19、11和7。主要分析包括比较赫尔基莫25分功能障碍指数量表的平均分。除了在55名患者的12至24个月亚组和11名患者的48至60个月亚组中出现的微小、临床上无重要意义的改善外,各分组的治疗前和治疗后赫尔基莫平均分之间没有显著差异。109名患者的平均随访时间约为2年,90%的患者赫尔基莫评分保持不变或有所改善,10%的患者评分从2至5个赫尔基莫分值增加或恶化。我们得出结论,我们样本中的正畸治疗不是TMD的重要病因因素。